Skip to main content
Livermore
Livermore
ZHEN

Evercore Wealth Management, LLC

SEC CIK
0001482689
Latest filing
Aug 14, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Evercore Wealth Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
2,061
Value
$1.02M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of VRTX by Evercore Wealth Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,061$1.02M<0.1%−37−1.8%ReducedHolders
Q1 20262,098$936.8K<0.1%−8−0.4%ReducedHolders
Q4 20252,106$954.8K<0.1%00.0%UnchangedHolders
Q3 20252,106$824.8K<0.1%−22−1.0%ReducedHolders
Q2 20252,128$947.4K<0.1%+27+1.3%AddedHolders
Q1 20252,101$1.02M<0.1%+278+15.2%AddedHolders
Q4 20241,823$734.1K<0.1%−50−2.7%ReducedHolders
Q3 20241,873$871.1K<0.1%00.0%UnchangedHolders
Q2 20241,873$877.9K<0.1%00.0%UnchangedHolders
Q1 20241,873$782.9K<0.1%+12+0.6%AddedHolders
Q4 20231,861$757.2K<0.1%+139+8.1%AddedHolders
Q3 20231,722$598.8K<0.1%+2+0.1%AddedHolders
Q2 20231,720$605.3K<0.1%+19+1.1%AddedHolders
Q1 20231,701$535.9K<0.1%+22+1.3%AddedHolders
Q4 20221,679$484.9K<0.1%+35+2.1%AddedHolders
Q3 20221,644$476.0K<0.1%+50+3.1%AddedHolders
Q2 20221,594$449.0K<0.1%00.0%UnchangedHolders
Q1 20221,594$416.0K<0.1%−28−1.7%ReducedHolders
Q4 20211,622$356.0K<0.1%−31−1.9%ReducedHolders
Q3 20211,653$300.0K<0.1%+4+0.2%AddedHolders
Q2 20211,649$332.0K<0.1%−276−14.3%ReducedHolders
Q1 20211,925$414.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.